Trwa ładowanie...
do9si70
espi

SOPHARMA AD - Current report 21 buy back 14022013 (21/2013)

SOPHARMA AD - Current report 21 buy back 14022013 (21/2013)
Share
do9si70
POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 21 / 2013
Date of issue: 2013-02-14
Short name of the issuer
SOPHARMA AD
Subject
Current report 21 buy back 14022013
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
The Board of Directors of SOPHARMA AD (the ?Company") hereby informs that from 7 February 2012 up to and including 13 February 2013 the Company bought 13439 own shares representing 0.0102% of the share capital of the Company, to the total value of BGN 30490.38 on the Bulgarian Stock Exchange. The average price per share was BGN 2.27. The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010. The total number of own shares after these transactions is 3573808, representing 2.71% of the share capital of the Company.
Annexes
File Description
Current report 21 buy back 14022013.doc Current report 21 buy back 14022013

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2013-02-14 Ognian Donev Executive Director

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

do9si70

Podziel się opinią

Share
do9si70
do9si70